Use of synthetic vitamin B1 derivative for preparing ophthalmocace medicament

A technology for use, eye diseases, applied in the field of medicine

Inactive Publication Date: 2008-08-27
BEIJING RUNDEKANG MEDICAL TECH CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But there is no evidence that vitamin B1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of synthetic vitamin B1 derivative for preparing ophthalmocace medicament
  • Use of synthetic vitamin B1 derivative for preparing ophthalmocace medicament
  • Use of synthetic vitamin B1 derivative for preparing ophthalmocace medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1 tablet

[0023] prescription:

[0024]

[0025] Tablets are prepared according to conventional preparation techniques.

[0026] Usage: Take orally, 1 tablet each time, 1-3 times a day

Embodiment 2

[0027] Embodiment 2: capsules

[0028] prescription:

[0029]

[0030] Capsules are prepared according to the conventional preparation process.

[0031] Usage: Take orally, 1 capsule each time, 1-3 times a day

Embodiment 3

[0032] Example 3: Orally disintegrating tablet

[0033] prescription:

[0034]

[0035] Orally disintegrating tablets were prepared according to the conventional preparation process.

[0036] Usage: Take orally, 1 tablet each time, 1-3 times a day

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the use of benfotiamine (a synthetic derivative of vitamin B1) in preparing drugs for treating diabetic retinopathy, that is, a new clinical indication thereof. Benfotiamine can reduce the formation of 6-phosphofructose and 3-phosphoglyceraldehyde by activating the pentose phosphate pathway, thereby blocking abnormal metabolism pathways including DAG-PKC pathway, aminohexose pathway, polyalcohol pathway and AGEs formation pathway and preventing hyperglycemia-induced damage to retinal capillary endothelial cells. The compound is combined with pharmaceutically-acceptable adjuvant to prepare pharmaceutical preparations suitable for oral intake at a daily dose of 5-100mg, 1-3 times daily.

Description

technical field [0001] The invention relates to the use of a synthetic vitamin B1 derivative benfotiamine in the preparation of eye disease medicines, preferably in the preparation of diabetes-induced retinopathy medicines, belonging to the technical field of medicine. Background technique [0002] Benfotiamine, a fat-soluble derivative of thiamine, is a synthetic vitamin B1 derivative that is slightly soluble in water. Synthesized in Japan in the 1960s, it was gradually used in the treatment of neuropathy, sciatica and other neuropathic pains caused by alcoholism after 1962. Since the 1990s, European scholars have carried out a series of studies on thiamine, especially benfotiamine, in the treatment of diabetes and its complications, and have made significant progress in recent years. The drug has been used in Europe for more than a decade to treat various conditions, including nerve damage associated with diabetes. But the drug has never been formally tested in rigorous ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/675A61P27/02A61P3/10
Inventor 陈瑞晶
Owner BEIJING RUNDEKANG MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap